PT  - JOURNAL ARTICLE
AU  - Eric Soule
AU  - Maansi Bansal-Travers
AU  - Rachel Grana
AU  - Scott McIntosh
AU  - Simani Price
AU  - Jennifer B Unger
AU  - Kevin Walton
TI  - Electronic cigarette use intensity measurement challenges and regulatory implications
AID  - 10.1136/tobaccocontrol-2021-056483
DP  - 2023 Jan 01
TA  - Tobacco Control
PG  - 124--129
VI  - 32
IP  - 1
4099  - http://tobaccocontrol.bmj.com/content/32/1/124.short
4100  - http://tobaccocontrol.bmj.com/content/32/1/124.full
SO  - Tob Control2023 Jan 01; 32
AB  - Assessing tobacco use intensity allows researchers to examine tobacco use in greater detail than assessing ever or current use only. Tobacco use intensity measures have been developed that are specific to tobacco products, such as asking smokers to report number of cigarettes smoked per day. However, consensus on electronic cigarette use intensity measures that can be used for survey research has yet to be established due to electronic cigarette product and user behavior heterogeneity. While some survey measures that attempt to assess electronic cigarette use intensity exist, such as examining number of ‘times’ using an electronic cigarette per day, number of puffs taken from an electronic cigarette per day, volume of electronic cigarette liquid consumed per day, or nicotine concentration of electronic cigarette liquid, most measures have limitations. Challenges in electronic cigarette measurement often stem from variations across electronic cigarette device and liquid characteristics as well as the difficulty that many electronic cigarette users have regarding answering questions about their electronic cigarette device, liquid, or behavior. The inability for researchers to measure electronic cigarette use intensity accurately has important implications such as failing to detect unintended consequences of regulatory policies. Development of electronic cigarette use intensity measures, though not without its challenges, can improve understanding of electronic cigarette use behaviors and associated health outcomes and inform development of regulatory policies.